Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

According to Benzinga Pro, Pfizer's peer group average for short interest as a percentage of float is 3.60%, which means the ...

Pfizer (PFE) closed the last trading session at $22.79, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...

Consolidation is likely to continue, with the indices attempting to defend the previous Thursday’s low in the upcoming ...

Pfizer share price rallied 12% hitting ₹5,097.40 on the NSE. After the company posted a solid set of Q4 numbers and declared ...

Pfizer stock (NYSE: PFE) recently reported its Q1 results, with revenues missing and earnings exceeding the street estimates. The company reported revenue of $13.7 billion and adjusted earnings of ...